DK0821969T3 - Medicinsk sammensætning omfattende TCF-II - Google Patents

Medicinsk sammensætning omfattende TCF-II

Info

Publication number
DK0821969T3
DK0821969T3 DK97100939T DK97100939T DK0821969T3 DK 0821969 T3 DK0821969 T3 DK 0821969T3 DK 97100939 T DK97100939 T DK 97100939T DK 97100939 T DK97100939 T DK 97100939T DK 0821969 T3 DK0821969 T3 DK 0821969T3
Authority
DK
Denmark
Prior art keywords
tcf
medical composition
derived
wound healing
particularly effective
Prior art date
Application number
DK97100939T
Other languages
English (en)
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Kanji Higashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja
Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja
Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of DK0821969T3 publication Critical patent/DK0821969T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97100939T 1992-07-16 1993-07-16 Medicinsk sammensætning omfattende TCF-II DK0821969T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP21222992A JP3380573B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP21222792A JP3619526B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP4234198A JPH0656692A (ja) 1992-08-10 1992-08-10 Ｔｃｆ−ｉｉを有効成分とする創傷治療剤
EP93305602A EP0588477B1 (en) 1992-07-16 1993-07-16 Medicinal composition comprising TCF-II

Publications (1)

Publication Number Publication Date
DK0821969T3 true DK0821969T3 (da) 2007-03-26

Family

ID=27329338

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97100939T DK0821969T3 (da) 1992-07-16 1993-07-16 Medicinsk sammensætning omfattende TCF-II
DK93305602.0T DK0588477T3 (da) 1992-07-16 1993-07-16 Medicinsk præparat omfatende TCF-11

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK93305602.0T DK0588477T3 (da) 1992-07-16 1993-07-16 Medicinsk præparat omfatende TCF-11

Country Status (7)

Country Link
EP (3) EP0821969B1 (da)
KR (1) KR100271087B1 (da)
AT (3) ATE159171T1 (da)
CA (1) CA2100720C (da)
DE (3) DE69334281D1 (da)
DK (2) DK0821969T3 (da)
ES (2) ES2276409T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0653211B1 (en) * 1992-07-16 2001-10-17 Snow Brand Milk Products Co., Ltd. Blood coagulation normalizer containing tcf-ii as active ingredient
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
NZ298141A (en) * 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
AU734766B2 (en) 1997-03-14 2001-06-21 Atlas Pharmaceuticals Inc. Agent for preventing and/or treating cachexia
JP3961064B2 (ja) 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904753A (en) * 1970-02-20 1975-09-09 Research Corp Clinically active bovine growth hormone fraction
JPS58146293A (ja) 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
US4708948A (en) 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
DE3419184A1 (de) 1984-05-23 1985-11-28 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja) 1985-10-28 1987-05-13 Yoshitomi Pharmaceut Ind Ltd 細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
JPS6410998A (en) 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
DE69133492T2 (de) * 1990-06-11 2006-08-10 Nakamura, Toshikazu Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
EP0539590B1 (en) * 1990-07-13 1999-03-31 Snow Brand Milk Products Co., Ltd. Plasmid containing dna which codes for the amino acid sequence of tcf-ii, transformed cell, and production of physiologically active substance by using the same

Also Published As

Publication number Publication date
CA2100720A1 (en) 1994-01-17
AU673835B2 (en) 1996-11-28
DE69334087T2 (de) 2007-07-05
DE69314586D1 (de) 1997-11-20
EP0588477A2 (en) 1994-03-23
DE69334281D1 (de) 2009-05-28
KR940005286A (ko) 1994-03-21
DE69334087D1 (de) 2007-01-04
DE69314586T2 (de) 1998-02-19
DK0588477T3 (da) 1998-03-30
EP1719522A1 (en) 2006-11-08
EP1719522B1 (en) 2009-04-15
EP0821969A3 (en) 2000-12-13
KR100271087B1 (en) 2000-11-01
ES2110057T3 (es) 1998-02-01
ATE428438T1 (de) 2009-05-15
EP0821969A2 (en) 1998-02-04
EP0588477B1 (en) 1997-10-15
EP0588477A3 (en) 1994-05-25
EP0821969B1 (en) 2006-11-22
CA2100720C (en) 2003-03-11
ATE345809T1 (de) 2006-12-15
ES2276409T3 (es) 2007-06-16
ATE159171T1 (de) 1997-11-15
AU4194593A (en) 1994-01-20

Similar Documents

Publication Publication Date Title
FI933770A7 (fi) Farmaseuttisia koostumuksia ihotautien hoitamiseen
FI963696L (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
NO910340L (no) Topiske preparater for behandling av menneskenegler.
DE69814394D1 (de) Verwendung von levobupivacain
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
GR3035762T3 (en) Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
GR3032224T3 (en) Therapeutic agent for threatened abortion.
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE206056T1 (de) Therapeutisches agens für neutropenie
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
KR930703003A (ko) 피부질환치료용 제약 조성물